Serena Williams Joins Ro in GLP-1 Weight-Loss Campaign

Telehealth company Ro has announced a multi-year partnership with tennis champion Serena Williams to promote GLP-1 weight-loss treatments, marking Williams' first public endorsement of the medication. Williams shared her personal journey of losing 31 pounds over eight months using GLP-1 injections to manage post-pregnancy weight, emphasizing that even top athletes like herself can struggle with weight loss. The campaign aims to increase awareness and accessibility of these treatments, with Williams serving as a national ambassador to encourage others to seek support for their health goals. Williams' husband, Reddit co-founder Alexis Ohanian, is an investor and board member of Ro, which recently expanded its offerings to include branded GLP-1 drugs like Zepbound through partnerships with pharmaceutical companies Eli Lilly and Novo Nordisk. The collaboration highlights the growing role of telehealth platforms in weight management and women's health, amidst rising competition in the market for GLP-1 medications and forthcoming oral drug approvals. The campaign has received mixed reactions, with some applauding Williams' openness and others questioning the financial ties involved.